FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Pharmaceuticals Clobetasol Propionate Foam Recall

Clobetasol Propionate Foam, 0

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Dec 18, 2019
Recall ID
D-0618-2020
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Clobetasol Propionate Foam starting Nov 15, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0618-2020 on Dec 18, 2019. Reason: Defective delivery system; product is not foaming or is coming out as liquid. Status: Terminated.

Why it was recalled

Defective delivery system; product is not foaming or is coming out as liquid.

Product description

Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430

Lot numbers, UPCs & expiration codes

a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0618-2020
Classification
Class III
Status
Terminated
Recall initiated
Nov 15, 2019
FDA report date
Dec 18, 2019
Quantity
a) 34521 bottles; b) 16930 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0618-2020, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
84282
Address
750 Corporate Dr
Code information
a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021
Postal code
07430-2009
Report date
Dec 18, 2019
Product type
Drugs
Recall number
D-0618-2020
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
a) 34521 bottles; b) 16930 bottles
Termination date
Mar 15, 2024
Reason for recall
Defective delivery system; product is not foaming or is coming out as liquid.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430
Distribution pattern
Nationwide
Recall initiation date
Nov 15, 2019
Initial firm notification
Letter
Center classification date
Dec 10, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0618-2020, published Dec 18, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls